The estimated Net Worth of Robert G Conway is at least $592 Tisíc dollars as of 19 November 2020. Mr. Conway owns over 4,149 units of Agile Therapeutics Inc stock worth over $34,573 and over the last 7 years he sold AGRX stock worth over $0. In addition, he makes $557,487 as Senior Vice President and Chief Supply Chain Officer at Agile Therapeutics Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Conway AGRX stock SEC Form 4 insiders trading
Robert has made over 1 trades of the Agile Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 4,149 units of AGRX stock worth $7,302 on 19 November 2020.
The largest trade he's ever made was exercising 4,149 units of Agile Therapeutics Inc stock on 19 November 2020 worth over $7,302. On average, Robert trades about 346 units every 0 days since 2018. As of 19 November 2020 he still owns at least 22,896 units of Agile Therapeutics Inc stock.
You can see the complete history of Mr. Conway stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Conway biography
Robert G. Conway J.D. serves as Senior Vice President and Chief Supply Chain Officer of the Company. He has over 25 years of experience in domestic and international operating companies, with a background in the medical device, pharmaceutical and consumer products industries. He was founder of R. G. Conway and Associates, Inc. Prior to forming his consulting company, he began his career in healthcare with Johnson and Johnson, and later joined a supported venture-backed medical device company operating as President and Chief Operating Officer. He received a Bachelor of Science in Mechanical Engineering from New Jersey Institute of Technology.
What is the salary of Robert Conway?
As the Senior Vice President and Chief Supply Chain Officer of Agile Therapeutics Inc, the total compensation of Robert Conway at Agile Therapeutics Inc is $557,487. There are 5 executives at Agile Therapeutics Inc getting paid more, with Alfred Altomari having the highest compensation of $1,301,370.
How old is Robert Conway?
Robert Conway is 63, he's been the Senior Vice President and Chief Supply Chain Officer of Agile Therapeutics Inc since 2019. There are 5 older and 13 younger executives at Agile Therapeutics Inc. The oldest executive at Agile Therapeutics Inc is Ajit Shetty, 73, who is the Independent Director.
What's Robert Conway's mailing address?
Robert's mailing address filed with the SEC is 500 COLLEGE ROAD EAST, SUITE 310, , PRINCETON, NJ, 08540.
Insiders trading at Agile Therapeutics Inc
Over the last 10 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor a Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.
What does Agile Therapeutics Inc do?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
What does Agile Therapeutics Inc's logo look like?
Complete history of Mr. Conway stock trades at Agile Therapeutics Inc
Agile Therapeutics Inc executives and stock owners
Agile Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Alfred Altomari,
Chairman of the Board, Chief Executive Officer -
Alfred F. Altomari,
Chairman & CEO -
Geoffrey Gilmore,
Senior Vice President, General Counsel, Corporate Secretary -
Geoffrey P. Gilmore,
Sr. VP, Gen. Counsel & Corp. Sec. -
Dr. Paul Korner M.B.A., M.D.,
Sr. VP & Chief Medical Officer -
Robert Conway,
Senior Vice President and Chief Supply Chain Officer -
Dennis P. Reilly,
Sr. VP & CFO -
John Hubbard,
Independent Director -
James Tursi,
Independent Director -
Seth Fischer,
Lead Independent Director -
Ajit Shetty,
Independent Director -
Sharon Barbari,
Independent Director -
Sandra Carson,
Director -
Paul Korner,
Chief Medical Officer -
Dennis Reilly,
Chief Financial Officer, Senior Vice President -
Dr. Kathryn MacFarlane Pharm.D.,
Advisor -
Robert G. Conway M.E.,
Sr. VP & Chief Supply Chain Officer -
Joseph D'Urso,
Controller -
Dr. Paul Korner,
Sr. VP & Chief Medical Officer -
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.,
Consultant -
Robert G. Conway,
Sr. VP & Chief Supply Chain Officer -
Amy Welsh,
VP of Marketing -
Matthew Riley,
Head of Investor Relations & Corp. Communications -
Jason Butch,
VP & Chief Accounting Officer -
Katie Mac Farlane,
Chief Commercial Officer -
Scott M Coiante,
Chief Financial Officer -
Karen Hong,
Director -
Renee Selman,
Chief Commercial Officer -
Jay Schreiber Alain Pro Que...,
-
William Mckee,
Director -
Abhijeet J Lele,
Director -
Amy Welsh,
Chief Commercial Officer -
Capital Iii Llc Care Capita...,
-
Elizabeth Garner,
Sr. VP & Chief Medical Officer -
Advisors Llcperceptive Life...,
-
Ab Investor,
10% owner -
Andrew N Schiff,
Director -
Josephine Torrente,
Director